Akzo Nobel N.V.
AKZOF
$55.95
-$1.73-3.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.75B | 2.79B | 2.93B | 3.00B | 2.87B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.75B | 2.79B | 2.93B | 3.00B | 2.87B |
| Cost of Revenue | 1.65B | 1.70B | 1.74B | 1.77B | 1.69B |
| Gross Profit | 1.10B | 1.09B | 1.19B | 1.23B | 1.18B |
| SG&A Expenses | 891.34M | 635.32M | 892.69M | 931.03M | 888.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.05M | 1.07M | 5.50M | -1.08M | 1.09M |
| Total Operating Expenses | 2.54B | 2.65B | 2.64B | 2.70B | 2.58B |
| Operating Income | 210.47M | 141.77M | 292.43M | 298.15M | 290.94M |
| Income Before Tax | 177.85M | 101.27M | 271.55M | 262.63M | 273.57M |
| Income Tax Expenses | 50.51M | 62.89M | 84.65M | 57.05M | 61.88M |
| Earnings from Continuing Operations | 127.33M | 38.37M | 186.89M | 205.58M | 211.69M |
| Earnings from Discontinued Operations | -- | -- | -- | 1.08M | -1.09M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.73M | -15.99M | -7.70M | -16.15M | -14.11M |
| Net Income | 112.60M | 22.39M | 179.20M | 190.51M | 196.49M |
| EBIT | 210.47M | 141.77M | 292.43M | 298.15M | 290.94M |
| EBITDA | 309.39M | 241.97M | 397.97M | 397.17M | 387.55M |
| EPS Basic | 0.66 | 0.13 | 1.05 | 1.12 | 1.15 |
| Normalized Basic EPS | 0.56 | 0.27 | 0.96 | 0.87 | 0.92 |
| EPS Diluted | 0.65 | 0.13 | 1.04 | 1.11 | 1.15 |
| Normalized Diluted EPS | 0.56 | 0.26 | 0.96 | 0.87 | 0.92 |
| Average Basic Shares Outstanding | 170.80M | 170.80M | 170.80M | 170.70M | 170.60M |
| Average Diluted Shares Outstanding | 172.58M | 175.00M | 171.58M | 170.70M | 170.75M |
| Dividend Per Share | -- | 1.64 | 0.00 | 0.47 | -- |
| Payout Ratio | 5.61% | 247.62% | 3.07% | 154.24% | 4.42% |